Career history of Jim Wang
Former positions of Jim Wang
| Companies | Position | Start | End |
|---|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | General Counsel | 23/04/2021 | 01/08/2023 |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Director/Board Member | - | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
| PTC THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Training of Jim Wang
| University of Illinois | Doctorate Degree |
| The Pennsylvania State University | Masters Business Admin |
Statistics
International
| United States | 8 |
| Japan | 2 |
Operational
| Corporate Officer/Principal | 4 |
| General Counsel | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| PTC THERAPEUTICS, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Stock Market
- Insiders
- Jim Wang
- Experience